Effect of momordica charantia fruit extract on normal and alloxan-diabetic rats

International Journal of Pharmacology

Volumn 7, Issue 4, 2011, Pages 532-535

  Kolawole, O T ^a   Abiona, F E ^a   Kolawole, S O ^a   Ayankunle, A A ^a   Olaniran, I ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Anti diabetic; Chlorpropamide; Hypoglycemic; Intaperitoneal; Methanol; Oxidative method

Indexed keywords

ALLOXAN; CHLORPROPAMIDE; GLUCOSE; METHANOL; MOMORDICA CHARANTIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; MALE; MOMORDICA CHARANTIA; NONHUMAN; RAT; SOLVENT EXTRACTION; TREATMENT RESPONSE;

EID: 79959383077     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.532.535     Document Type: Article

References (23)

1. Adewole, S.O. and J.A.O. Ojewole, 2008. Protective effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on serum lipid profiles and oxidative stress in hepatocytes of streptozotocin-treated diabetic rats. Afr. J. Tradit. Complement. Altern. Med., 6: 30-41.
2. Assubaie, N.F. and M.M. El-Garawany, 2004. Evaluation of some important chemical constituents of Momordica charantia cultivated in Hofuf, Saudi Arabia. J. Biological Sci., 4: 628-630.
3. Ataman, J.E., D.B. Gnllo, E.K.I. Omongbai, M. Idu, F. Amaechina, V. Okonji and B.A. Ayinde, 2006. Effect of methanolic extract of Momordica charantia L. leaves on alloxan treated wistar rats. J. Medical Sci., 6: 828-832.
4. Bavarva, J.H. and A.V.R.L. Narasimhacharya, 2007. Comparative antidiabetic, hypolipidemic and antioxidant properties of Phyllanthus niruri. in normal and diabetic rats. Pharm. Biol., 45: 569-574.
5. Boyle, J.P., A.A. Honrycult, K.M. Narayan, T.J. Hoerger, L.S. Geiss, H. Chen and T.J. Thompson, 2001. Projection of diabetes burden through 2050. Impact of changing demography and disease prevalence in the US. Diabetes Care, 24: 1936-1940.
6. Ceriello, A., 2003. New insight on oxidative stress in diabetic complications may lead to a casual antioxidant therapy. Diabetic Care, 26: 1589-1596.
7. El-Ghaffar, N.A. and N.H. El-Said, 2006. Hypoadiponectinaemia in Egyptian patients with type ii diabetes mellitus with vascular complications. J. Med. Sci., 6: 626-630.
8. Grover, J.K., S. Yadav and V. Vats, 2002. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol., 81: 81-100.
9. Keen, R.W., A.C. Deacon, H.T. Delves, J.A. Moreton and P.G. Frost, 1994. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad. Med. J., 70: 113-114.
10. Krishna Murthy, B., S. Nammi, M.K. Kota, R. V. Krishna Rao, N. Koteswara Rao and A. Annapurna, 2004. Evaluation of hypoglycaemic effects of Datura metel Linn. Seeds in normal and alloxan induced diabetic rats. J. Ethnopharmacol., 9: 95-98.
11. Kumar, R., S. Balaji, T.S. Uma and P.K. Sehgal, 2009. Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPARy and P13K. J. Ethnopharmacol., 126: 533-537.
12. Manzella, D., M. Barbieri, E. Ragno and G. Paolisso, 2001. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am. J. Clin. Nutri., 73: 1052-1057.
13. Miura, T., C. Itoh, N. Iwamoto, M. Kato, M. Kawai, S.R. Park and I. Suzuki, 2001. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutr. Sci. Vitaminol, 47: 340-344.
14. NTH, 1985. Guide for the use of laboratory animals. DHHS, PHS, NIH Publication No. 85-23 (1985 Revised).
15. Paul, A. and S.S. Raychaudhuri, 2010. Medicinal uses and molecular identification of two Momordica charantia varieties-a review. Elect. J. Biol., 6: 43-51.
16. Pavana, P., S. Sethupathy and S. Manoharan, 2008. Protective role of Tephrosia purpurea ethanolic seed extract on glycoprotein components in streptozotocin induced diabetic rats. Int. J. Pharmacol., 4: 114-119.
17. Raman, A. and C. Lau, 1996. Anti-diabetic properties and phytochemistry Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2: 249-250.
18. Rao, B.K., M.M. Kesavulu and C. Apparao, 2001. Antihyperglycemic activity of Momordica cymbalaria in alloxan diabetic rats. J. Ethnopharmacol., 78: 67-71.
19. Sathishsekar, D. and S. Rajasekaran, 2007. Protective role of Momordica charantia seeds extract on membrane bound ATPases and lysosomal hydrolases in rats with streptozotocin diabetes. J. Plant Sci., 2: 293-301.
20. Schnell, O. and E. Standi, 2006. Impaired glucose tolerance, diabetes and cardiovascular disease. Endocrinol. Pract, 12: 16-19.
21. Scoppola, A., F.R. Montecchi, G. Mezinger and A. Lala, 2001. Urinary mevelonate excretion rate in type 2 diabetes: Role of metabolic control. Artherosclerosis, 156: 357-361.
22. Sherry, A.K., G.S. Kumar, K. Sambaiah and P.V. Salimath, 2005. Effect of bittergourd {Momordica charantia) in glycaemic status in streptozotocin induced diabetic rats. PlantFoods HumanNutr., 60: 109-112.
23. Virella-Lopes, M.F. and G. Virella, 2003. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Fron. Biosci., 8: 750-768.